Technopath Clinical Diagnostics is a global leader in the development, manufacturing, and delivery of high-quality independent quality controls and QC data management software for the In-Vitro Diagnostics industry. The company's customers include hospitals, clinical laboratories, research facilities, CROs, and blood banks in over 120 countries globally, while its partners are the leading innovators of clinical diagnostics instruments and systems. Additionally, the company collaborates with experienced academic institutions and reference laboratories in research and development activities.
In February 2021, Technopath Clinical Diagnostics became part of LGC Clinical Diagnostics, a leading in vitro diagnostic (IVD) manufacturer of clinical diagnostic quality solutions and test components to the extended life science industry. The focus sectors of this incorporation include Clinical Biochemistry, Serology, Molecular Diagnostics, and Clinical Genomics. As part of LGC Clinical Diagnostics, Technopath is committed to improving patient healthcare by offering products and services that support accurate and reliable diagnostic results.
Founded in 2004, Technopath's partnership with LGC Clinical Diagnostics further solidifies its position as a key player in the in vitro diagnostics industry, with the potential for continued growth and impact within the healthcare sector.